Comments: New binciken Italiyanci ya gano cewa 25% na sababbin marasa lafiya da mai tsanani Dysfunction erectile suna karkashin 40.
TAMBAYOYI: Wannan bincike na bincike ya nuna cewa daya daga cikin marasa lafiya hudu da ke neman taimako na farko na likita don sabon farko ED ya kasance ƙuruci ne fiye da shekaru 40. Kusan rabin matasa sun sha wahala daga ED mai tsanani, tare da karuwar yawan marasa lafiya. A bayyane yake, samari maza sun bambanta da mutanen da suka tsufa a game da magungunan asibitoci da na zamantakewa.
J Jima'i Med. 2013 Jul;10(7):1833-41. Doi: 10.1111 / jsm.12179.
Capogrosso P, Colicchia M, Ventimiglia E, Castagna G, Clementi MC, Suardi N, Castiglione F, Briganti A, Cantiello F, Damiano R, Montorsi F, Salonia A.
source
Ma'aikatar Urology, Jami'ar Vita-Salutary San Raffaele, Milan, Italiya.
Abstract
GABATARWA:
Cutar da aka yi amfani da shi na Erectile (ED) wani ƙira ne a cikin maza a kan shekaru 40, kuma yawan ƙimar ya karu a cikin lokacin tsufa. An yi nazari sosai a tsakanin samari da kuma matsalolin da suka shafi ED a tsakanin samari.
AIM:
Binciken zamantakewar zamantakewar zamantakewa da kuma asibitoci na samari (a matsayin ≤ 40 shekaru) neman taimakon farko na likita don sabon saitin ED kamar yadda suke zama na farko na jima'i.
MUTANE:
Ana nazarin cikakkun bayanai na zamantakewar zamantakewa da kuma asibiti daga 439 a jere marasa lafiya. An shawo kan abubuwan da suka shafi kiwon lafiya da Charlson Comorbidity Index (CCI). Magunguna sun kammala Aiktawar Ƙaurarren Ƙasa na Erectile Function (IIEF).
KASA KASA KUMA KUMA:
Statisticsididdigar ƙididdiga ta gwada yanayin zamantakewar al'umma da bambance-bambance na asibiti tsakanin marasa lafiya na ED shekaru 40 da> shekaru 40.
Sakamakon:
Sabon farko ED kamar yadda cutar ta farko ta samo a cikin 114 (26%) maza ≤ 40 shekaru (na nufin [bambancin daidaitattun [SD]] shekarun: 32.4 [6.0]; range: 17-40 shekaru). Marasa lafiya years 40 shekaru suna da ƙananan ƙananan yanayin rashin lafiya (CCI = 0 a cikin 90.4% vs. 58.3%; χ (2), 39.12; P <0.001), ƙananan ƙananan ƙimar jikin jiki (P = 0.005), da kuma mafi girma yana nufin yawo jimillar jimlar testosterone (P = 0.005) idan aka kwatanta da waɗancan> shekarun 40. Patientsananan yara marasa lafiya na ED sun nuna alamun shan sigari da amfani da miyagun ƙwayoyi, idan aka kwatanta da tsofaffi (duk P ≤ 0.02). Rage saurin inzali ya fi zama sanadin lalacewa a cikin samari, yayin da cutar Peyronie ta kasance a cikin tsofaffin rukuni (duk P = 0.03). IIEF, an sami ƙimar ED mai tsanani a cikin 48.8% samari da 40% mazan maza, bi da bi (P> 0.05). Hakanan, ƙididdigar sassauƙa, mai-tsaka-tsaka, da matsakaiciyar ED ba su da bambanci sosai tsakanin ƙungiyoyin biyu.
TAMBAYOYI:
Wannan bincike na bincike ya nuna cewa daya daga cikin marasa lafiya hudu da ke neman taimako na farko na likita don sabon farko ED ya kasance ƙuruci ne fiye da shekaru 40. Akusan rabin samari sun sha wahala daga ED mai tsanani, tare da karuwar yawan marasa lafiya. A bayyane yake, samari maza sun bambanta da mutanen da suka tsufa a game da magungunan asibitoci da na zamantakewa.
© 2013 International Society for Jima'i Magunguna.
KEYWORDS:
Shekaru, Ayyukan Bincike, Ƙararruwa, Ƙararru, Dubuce-tsaren Ciwo, Yanayin Lafiya, Ƙasashen Duniya na Ayyukan Erectile, Abubuwan Dalili, Matasa
PMID: 23651423
Gabatarwa
Cutar da aka yi amfani da shi na Erectile (ED) wata ƙira ce a cikin maza a kan shekaru 40, kuma yawan yawan yawan kuɗi ya karu a cikin lokacin tsufa. [1].
Yawancin rubuce-rubuce game da batun ED yana buɗewa tare da irin wannan sanarwa, komai la'akari da la'akari da kowane yawan jama'a ko kabilanci,
na kowane masana kimiyya da nazarin / mai bincike ya kasance, da kuma kowane mujallar kimiyya inda aka wallafa rubuce-rubucen kansu. A wasu kalmomi, mazan da maza suka samu, yawancin fara farawa da ED [2].
A cikin layi daya, a hankali ED ya sami muhimmiyar rawa azaman madubin lafiyar lafiyar maza, yana ɗaukar babban mahimmanci a cikin jijiyoyin zuciya
filin [3-6]. Saboda haka, ya tabbata cewa ED ya kai mahimmaci ba kawai a fannin likitanci ba, har ma a fannin lafiyar jama'a, saboda tasirin sa a fannonin zamantakewar rayuwar mutum. Interestarin sha'awar wannan batun ya haifar da ci gaba da yawa
bincikar game da adadi da kuma matsalolin da ke tattare da ED a tsakanin sassan marasa lafiya [7, 8]; a cikin wannan mahallin, mafi yawan bayanai da aka buga sune ma'anar yawancin maza da tsofaffi, kuma musamman ga maza a sama da shekaru 40 [7-9]. Hakika, tsofaffi maza, da tsofaffi, yawanci sukan sha wahala daga yanayin da ba su da magunguna kamar su ciwon sukari, kiba, cututtukan zuciya na zuciya (CVD), da ƙananan cututtukan urinary tract (LUTS) - dukansu sune abubuwan haɗari ga ED [7-12].
Hakanan, haɓakawa da halayen halayyar ED a tsakanin samari sunyi nazari sosai. Bayanan da aka samu a kan waɗannan maza sun nuna yawancin adadin ED wanda ke tsakanin 2% da kusan 40% a cikin kananan yara fiye da shekaru 40 [13-16]. Bugu da} ari, bayanan da aka wallafa, sun jaddada muhimmancin ED a cikin samari, ko da yake wannan takaddama na mutane ba su da alaƙa da raba irin abubuwan da suka shafi kiwon lafiya na tsofaffin maza da suke kokawa game da rashin lalacewa. [15, 16], don haka ya sa mutane su yi imani da cewa wani abu na psychogenic yafi kowa a cikin marasa lafiya marasa lafiya da haɗuwa da haɗuwa ko aikin da ke cikin wucin gadi. [17].
A takaice dai, kusan dukkanin nazarin sunyi rahoton adadin ED dangane da yawancin jama'a, kuma a wannan ma'anar babu wani labari mai amfani
zuwa yau da kullum aikin asibiti; Hakazalika, babu bayanai a fili game da waɗannan marasa lafiya wadanda suke neman taimakon likita a cikin wurin asibiti don matsalar da suka danganci ingancin haɗin su. A wannan hanya, mun nemi yin la'akari da adadi da masu hangen nesa na ED a cikin samari (wanda aka ƙayyade cikakke ≤40 shekarun haihuwa) a matsayin ɓangare na ƙungiyar kwararru na Caucasian-Turai marasa lafiya neman likitoci na farko don yin jima'i a makarantar kimiyya ɗaya.
Hanyar
Population
Masanan sun dogara ne akan wata ƙungiya ta 790 a jere a cikin Caucasian-Turai marasa lafiya da ke neman jima'i don neman taimakon farko na likita don farawa tsakanin jinsin Janairu 2010 da Yuni 2012 a wata asibitin likita. Don ƙayyadadden ma'anar wannan nazarin binciken, kawai bayanai daga marasa lafiya da ke ƙuntatawa da ED sunyi la'akari. Don wannan maƙasudin, ED an bayyana shi azaman ƙuntataccen rashin iya cimma ko kula da tsararren da ya dace don yin jima'i mai kyau [18].
An gwada marasa lafiya da cikakkun tarihin lafiyar lafiyar jiki, ciki har da bayanan zamantakewa. An shawo kan abubuwan da suka shafi kiwon lafiya da Charlson Comorbidity Index (CCI) [19] duka a matsayin mai ci gaba ko ƙayyadewa (watau 0 vs. 1 vs. ≥2). Mun yi amfani da Kayan Kayan Ƙasa na Duniya, Binciken 9th, Gyara Gyara. Alamar ma'auni ta jiki (BMI),
an ƙayyade nauyin nauyi a cikin kilo mita ta tsawo a mita mita, an dauke shi ga kowane mai haƙuri. Ga BMI, munyi amfani da cutoffs da aka samar
Cibiyoyin Lafiya na Ƙasar [20]: nauyi na al'ada (18.5-24.9), mai nauyi (25.0-29.9), da aji and1 kiba (-30.0). An bayyana hauhawar jini lokacin da aka ɗauki magungunan hawan jini da / ko don hawan jini (-140 mm Hg systolic ko -90 mm Hg diastolic). Hypercholesterolemia an bayyana lokacin da aka ɗauki maganin rage kiba da / ko cholesterol mai ƙarfi mai ƙarfi (HDL) shine <40 mg / dL. Hakanan, an bayyana hypertriglyceridemia lokacin da plasma triglycerides suka kasance -150 mg / dL [21]. Kwalejin Ilimi na Cholesterol na kasa - Ƙungiyar Kulawa da Adult III [21] an yi amfani da ma'aunin da aka yi amfani da su don nuna ƙwayar cuta (MeTs) a cikin dukan ƙungiyar 'yan adam tare da ED.
Don takamaiman dalilin wannan binciken kuma don yin la'akari da al'adar gama-gari ta dakin gwaje-gwaje na kimiyyar kimiyyar kimiyyar, sai muka zaba don auna matakan testosterone gaba daya (tT) ta hanyar amfani da hanyoyin nazari na kasuwanci. Hyfingonadism an bayyana shi azaman tT <3 ng / mL [22].
Bayan haka, an sakar da marasa lafiya bisa ga matsayin haɗin kansu (wanda aka sani da "haɗin zinare" idan marasa lafiya sun kasance da abokin tarayya
don watanni shida ko fiye; in ba haka ba "babu dangantaka mai zaman kansa" ko kuma gwauruwa). Haka kuma, an rarraba marasa lafiya bisa ga matsayinsu na ilimi a cikin rukunin ilimi (watau makarantar sakandare da sakandare), ƙungiyar digiri na makaranta, da kuma maza da ke da digiri na ilimi (watau jami'a / digiri na biyu).
Bugu da ƙari, an bukaci magunguna su kammala Nassin Duniya na Erectile Function (IIEF) [23]; don samar da hanyar tunani don fassara magungunan ED sosai, mun yi amfani da tsarin aikin ƙungiyar IIEF-erectile kamar yadda Cappelleri et al. [24].
Matsalar littafi da kuma sauran matsalolin karatu da rubuce-rubuce an cire su a cikin marasa lafiya.
An samo tattara bayanai ta bin ka'idojin da aka tsara a cikin Harkokin Helsinki; duk marasa lafiya sun rattaba hannu kan wata sanarwar da aka ba da izini don su ba da bayanin kansu ba don nazarin kwanan nan ba.
Babban Matakan Matakan
Matsayin farko na binciken yanzu shine don tantance yawanci da kuma masu hango gangami na farko na ED a cikin samari masu neman taimakon farko na likita
a cikin asibitoci na yau da kullum, bisa ga yaduwar cututtuka na 40 da aka yi amfani da shi na yau da kullum. Matsayin na ƙarshe shi ne ya tantance ko yawan aikin jima'i, kamar yadda aka zana tare da ɗakunan IIEF, ya sha bamban a cikin samari fiye da shekaru 40 idan aka kwatanta da tsofaffin marasa lafiya.
ilimin kididdiga Analysis
Don takamaiman dalilin wannan bincike, marasa lafiya tare da sabon farawa ED da neman taimakon likita na farko sun kasance cikin maza ≤40 shekara da mutane> 40 shekara. An yi amfani da ƙididdigar ƙididdiga don kwatanta ƙirar asibiti da halayyar zamantakewar al'umma na
ƙungiyoyi biyu. Ana gabatar da bayanai a matsayin ma'anar (karkatacciyar karkatacciyar [SD]). Ƙididdigar mahimmanci na bambance-bambance a cikin hanyoyi da halayen su
jarraba tare da tailed biyu t-gwajin gwaji da madauri (χ2) gwaje-gwaje, bi da bi. An gudanar da nazarin ilimin lissafi ta amfani da 13.0 (IBM Corp., Armonk, NY, USA). Dukkan gwaje-gwaje sun kasance guda biyu, tare da matakin da aka saita a 0.05.
results
Sabon farkon ED kamar yadda cutar ta farko aka samo a cikin marasa lafiya 439 (55.6%) daga cikin marasa lafiya 790. Daga cikinsu, 114 (25.9%) sun cika shekaru 40. Tebur 1 cikakkun bayanai game da halayen mutane da kuma bayanan fasali na dukan ƙungiyar marasa lafiya tare da ED, kamar yadda aka rarraba bisa ga yanke hukunci na shekaru 40. A cikin wannan mahallin, marasa lafiya ≤40 shekaru da haihuwa a lokacin da suka fara neman taimakon likita don ED ya nuna
ƙananan ƙananan yanayi (kamar yadda aka zana da CCI), ƙananan ƙimar BMI, ƙananan mutane da BMI suna nuna nauyin kisa da aji ≥1 kiba, ƙananan hauhawar jini da hypercholesterolemia, kuma mafi girma yana nufin tallata tT matakin idan aka kwatanta da wadanda suka fi girma a shekaru 40 (duk P ≤ 0.02). Sabanin haka, ba a lura da bambance-bambance tsakanin ƙungiyoyi dangane da yawan hauhawar jini, MetS, da hypogonadism (Tebur 1). Bugu da ƙari, ƙananan ƙwararruwar ED sun nuna yawan halayen ɗan kishili da jima'i da kuma rashin daidaito na haɓaka (duk P ≤ 0.02). Babu wani bambanci mai mahimmanci da aka lura gwargwadon matsayin ilimin tsakanin ƙungiyoyi. Significantlyididdigar mafi girma na saurin haɗuwa (ko dai rayuwa ko samu) an lura da shi a cikin ƙananan yara fiye da tsofaffi; akasin haka, cutar Peyronie ta kasance a cikin tsofaffin rukuni (duka P = 0.03), yayin da babu bambance-bambance a cikin yawan ƙananan sha'awar jima'i tsakanin ƙungiyoyin biyu (Tebur 1).
Marasa ≤40 shekaru | Marasa lafiya> shekaru 40 | P darajar* | |
---|---|---|---|
| |||
No. of marasa lafiya (%) | 114 (25.9) | 325 (74.1) | |
Shekaru (shekaru; yana nufin [SD]) | 32.4 (6.0) | 57.1 (9.7) | |
range | 17-40 | 41-77 | |
CCI (A'a. [%]) | <0.001 (χ2, 39.12) | ||
0 | 103 (90.4) | 189 (58.3) | |
1 | 6 (5.3) | 62 (19) | |
2+ | 5 (4.4) | 74 (22.7) | |
BMI (kg / m2; ma'ana [SD]) | 25.1 (4.1) | 26.4 (3.7) | 0.005 |
BMI (NIH rarraba) (A'a. [%]) | 0.002 (χ2, 15.20) | ||
1 (0.9) | 0 (0) | ||
18.5-24.9 | 63 (56.5) | 126 (38.7) | |
25-29.9 | 34 (29.6) | 157 (48.3) | |
≥30 | 16 (13) | 42 (13) | |
Hawan jini (A'a. [%]) | 6 (5.3) | 122 (37.5) | <0.001 (χ2, 42.40) |
Hypercholesterolemia (A'a. [%]) | 4 (3.5) | 38 (11.7) | 0.02 (χ2, 5.64) |
Hypertriglyceridemia (A'a. [%]) | 0 (0.0) | 10 (3.1) | 0.12 (χ2, 2.37) |
MeTs (A'a. [%]) | 2 (1.8) | 10 (3.1) | 0.57 (χ2, 0.74) |
tT (ng / mL; nufi [SD]) | 5.3 (2.0) | 4.5 (1.8) | 0.005 |
Hypogonadism (duka <3 ng / mL) (A'a. [%]) | 12 (10.3) | 54 (16.6) | 0.14 (χ2, 2.16) |
Halin jima'i (A'a. [%]) | 0.02 (χ2, 5.66) | ||
Namiji | 109 (95.6) | 322 (99.1) | |
Jima'i | 5 (4.4) | 3 (0.9) | |
Halin dangantaka (A'a. [%]) | <0.001 (χ2, 27.51) | ||
Halin jima'i ≥6 watanni | 81 (71.4) | 303 (93.2) | |
Babu haɗin haɗin kai | 33 (28.6) | 22 (6.8) | |
Matsayin ilimin (No. [%]) | 0.05 (χ2, 9.30) | ||
Makarantar sakandare | 0 (0) | 22 (6.8) | |
Makarantar sakandaren | 20 (17.5) | 64 (19.7) | |
Makaranta | 51 (44.7) | 141 (43.4) | |
Digiri na jami'ar | 43 (37.7) | 98 (30.2) | |
Harkokin jima'i masu rikitarwa (A'a. [%]) | |||
PE | 14 (12.4) | 20 (6.2) | 0.03 (χ2, 4.55) |
Low libido | 10 (8.8) | 23 (7.1) | 0.55 (χ2, 0.35) |
Peyronie ta cuta | 5 (4.4) | 37 (11.4) | 0.03 (χ2, 4.78) |
Table 2 ya lissafa magungunan da marasa lafiyar kungiyoyin biyu suka sha, an ware su ta dangin magunguna. Hakazalika, Tebur 2 Har ila yau, cikakkun bayanai game da kayayyakin wasan kwaikwayo da marasa lafiya suka ruwaito
rabuwa da shekaru. Maganin tsofaffi na ED sun karu da yawa
magungunan antihypertensive ga kowane iyali da thiazide
diuretics da lipid-ragewan kwayoyi kamar yadda idan aka kwatanta da maza ≤40 shekaru (duk P
≤ 0.02). Hakazalika, magunguna marasa lafiya sun karu da yawa
magungunan antidiabetics da magungunan asibiti, haruffan haruffan fata don LUTS, da kuma proton
yin amfani da magunguna idan aka kwatanta da matasa (duk P ≤ 0.03).
Marasa ≤40 shekaru | Marasa lafiya> shekaru 40 | P darajar* | |
---|---|---|---|
| |||
No. of marasa lafiya (%) | 114 (25.9) | 325 (74.1) | |
Magungunan antihypertensive | |||
ACE-i | 1 (0.9) | 47 (14.5) | <0.001 (χ2, 14.62) |
Angiotensin-II masu karɓar sakonnin | 2 (1.8) | 41 (12.6) | 0.002 (χ2, 9.95) |
Masu Beta-1 | 2 (1.8) | 44 (13.5) | 0.0009 (χ2, 11.12) |
Masanan kwayoyi | 0 (0.0) | 39 (12.0) | 0.002 (χ2, 13.57) |
diuretics | |||
Madauriyar diuretics | 0 (0.0) | 6 (1.8) | 0.33 (χ2, 0.94) |
Thurezide diuretics | 0 (0.0) | 18 (5.5) | 0.02 (χ2, 5.20) |
Sauran kwayoyi na zuciya | |||
Digoxin | 0 (0.0) | 7 (2.2) | 0.24 (χ2, 1.36) |
Antiarrhythmic kwayoyi | 1 (0.9) | 6 (1.8) | 0.82 (χ2, 0.05) |
Magunguna masu guba | 1 (0.9) | 10 (3.1) | 0.35 (χ2, 0.89) |
Antiplatelet kwayoyi | 1 (0.9) | 1 (1.8) | 0.82 (χ2, 0.06) |
Magungunan rage kiba (statins & / ko fibrates) | 0 (0.0) | 43 (13.2) | 0.0001 (χ2, 15.21) |
Tsarin magunguna na tsakiya | |||
Magunguna Anticonvulsant | 1 (0.9) | 6 (1.8) | 0.82 (χ2, 0.05) |
Barbiturates | 0 (0.0) | 2 (0.6) | 0.99 (χ2, 0.00) |
Benzodiazepine | 2 (1.8) | 15 (4.6) | 0.29 (χ2, 1.11) |
Neuroleptics | 2 (1.8) | 3 (0.9) | 0.79 (χ2, 0.07) |
Opioid kwayoyi | 0 (0.0) | 2 (0.6) | 0.99 (χ2, 0.00) |
SNRIs | 1 (0.9) | 1 (0.3) | 0.99 (χ2, 0.00) |
SSRIs | 8 (7.0) | 8 (2.5) | 0.06 (χ2, 3.65) |
Magungunan endocrinological | |||
Antiandrogenic kwayoyi | 0 (0.0) | 3 (0.9) | 0.73 (χ2, 0.12) |
Antithyroid kwayoyi | 0 (0.0) | 1 (0.3) | 0.57 (χ2, 0.33) |
Thyroxin | 2 (1.8) | 17 (5.2) | 0.20 (χ2, 1.61) |
corticosteroids | 3 (2.6) | 12 (3.7) | 0.80 (χ2, 0.07) |
Darbepoetin | 0 (0.0) | 1 (0.3) | 0.57 (χ2, 0.33) |
Desmopressin | 0 (0.0) | 2 (0.6) | 0.99 (χ2, 0.00) |
Dandalin agonists | 2 (1.8) | 4 (1.2) | 1.00 (χ2, 0.00) |
Dalilan masu tayar da hankali | 4 (3.5) | 3 (0.9) | 0.14 (χ2, 2.19) |
Magungunan hypoglycemic | |||
Antidiabetic kwayoyi | 3 (2.6) | 32 (9.8) | 0.02 (χ2, 5.05) |
insulin | 3 (2.6) | 23 (7.1) | 0.13 (χ2, 2.31) |
Maganin numfashi na numfashi | |||
Anthistamines | 4 (3.5) | 12 (3.7) | 0.85 (χ2, 0.04) |
Beta2-agonist | 1 (0.9) | 3 (0.9) | 0.56 (χ2, 0.33) |
BPH / LUTS-related related kwayoyi | |||
5-alpha reductase inhibitors | 1 (0.9) | 6 (1.9) | 0.77 (χ2, 0.09) |
Alpha-blockers | 1 (0.9) | 41 (12.6) | 0.0005 (χ2, 12.04) |
Sauran kwayoyi | |||
Anticholinergic kwayoyi | 1 (0.9) | 1 (0.3) | 0.99 (χ2, 0.00) |
Immunomodulators / immunosuppressors | 3 (2.6) | 12 (3.7) | 0.80 (χ2, 0.07) |
Proton famfo masu hanawa | 2 (1.8) | 33 (10.2) | 0.008 (χ2, 6.98) |
Ƙwayoyin anti-inflammatory marasa amfani | 7 (6.1) | 14 (4.3) | 0.60 (χ2, 0.27) |
Triptans | 0 (0.0) | 1 (0.3) | 0.57 (χ2, 0.33) |
bitamin | 2 (1.8) | 11 (3.4) | 0.59 (χ2, 0.30) |
Uricosuric kwayoyi | 0 (0.0) | 17 (5.2) | 0.03 (χ2, 4.84) |
Cigarette shan taba (Babu. [%]) | 0.02 (χ2, 7.56) | ||
Masu smokers na yanzu | 43 (37.8) | 80 (24.6) | |
Masu shan taba na baya | 1 (0.9) | 7 (2.2) | |
Kada taba taba taba taba | 70 (61.3) | 238 (73.2) | |
Alcohol intake (kowane ƙara / mako) (A'a. [%]) | 0.52 (χ2, 0.41) | ||
A kai a kai | 88 (77.2) | 262 (80.6) | 0.16 (χ2, 1.93) |
Abincin giya (1-2 L / mako) | 26 (22.8) | 98 (30.2) | 0.96 (χ2, 0.00) |
Shan barasa (> 2 L / mako) | 4 (3.6) | 10 (3.1) | |
Magunguna marar kyau (duk wani nau'i) (A'a. [%]) | 24 (20.9) | 11 (3.4) | <0.001 (χ2, 34.46) |
Cannabis / marijuana | 24 (20.9) | 9 (2.8) | <0.001 (χ2, 37.29) |
Cocaine | 4 (3.5) | 0 (0.0) | 0.005 (χ2, 37.29) |
Heroin | 0 (0.0) | 3 (0.9) | 0.73 (χ2, 7.92) |
Babu wani bambance-bambance da aka samo don kowane dangin kwayoyi (Tebur 2).
matasa
Kwararrun likita na ED sun nuna yawan taba shan taba
da kuma yin amfani da magungunan ƙwayoyi (duka cannabis / marijuana da cocaine) kamar yadda
idan aka kwatanta da maza da suka wuce shekaru 40 (duk P ≤ 0.02). Babu wani bambance-bambance da aka samo dangane da shan barasa tsakanin kungiyoyi (Tebur 2).
Table 3 Karin bayani yana nufin (SD) scores ga maki na biyu na IIEF; babu
manyan bambance-bambance an kiyaye su ga kowane yankin IIEF tsakanin
matasa da kuma tsofaffin farawa na farko na ED. Haka kuma, maza ≤40 shekaru da haihuwa
ya nuna irin wannan kamala mai tsanani kamar yadda aka kwatanta
tare da tsofaffin marasa lafiya. Hakazalika, rates of m, m-da-matsakaici, da kuma
Adaidaicin ED bai bambanta sosai tsakanin ƙungiyoyi biyu ba
(Table 3).
IIEF-domains (ma'ana [SD]) | Marasa ≤40 shekaru | Marasa lafiya> shekaru 40 | P darajar* |
---|---|---|---|
| |||
IIEF-EF | 12.77 (8.7) | 14.67 (8.4) | 0.23 |
IIEF-IS | 5.9 (4.2) | 6.69 (4.1) | 0.33 |
IIEF-OF | 7.51 (3.2) | 7.06 (3.5) | 0.49 |
IIEF-SD | 6.98 (2.3) | 6.57 (2.1) | 0.36 |
IIEF-OS | 4.95 (2.6) | 5.06 (2.5) | 0.82 |
Cutar IIEF† (Babu [%]) | |||
Na'urar EF | 11 (9.3) | 39 (11.9) | 0.73 (χ2, 2.01) |
MD ED | 16 (14.0) | 55 (16.8) | |
Adalci mai tsabta ED | 10 (9.3) | 51 (15.8) | |
Adaidaicin ED | 21 (18.6) | 48 (14.9) | |
Mai tsanani ED | 56 (48.8) | 132 (40.6) |
tattaunawa
We
ya sake nazarin kwanan wata ƙungiyar ta Caucasian-Turai
masu aiki da jima'i suna neman taimakon likita na farko don sabon farko ED a
sabis guda ɗaya daga cikin ƙwararren ilimi a kan wani lokacin 30 don
tantance tsararru da halaye na mutane ≤40 shekaru da haihuwa kamar yadda
idan aka kwatanta da mutanen da suka wuce shekaru 40 a lokacin ED ganewar asali.
Mun gano cewa ɗaya daga cikin mutane hudu da ED yana ƙuruciya fiye da shekaru 40.
Bugu da ƙari, irin wannan rabo na ƙarami da mazan ED marasa lafiya yi
korafin mai tsanani ED. Hakazalika, ƙananan marasa lafiya da mazan jiya
ya sha ga kowane yankin IIEF, haka ya hada da sha'awar jima'i, kogasma
aiki, da kuma gamsuwa ta gaba. Saboda haka, kallo a matsayin
Dukkanin sun bayyana a gare mu a matsayin hoto mai ban tsoro daga asibiti na yau da kullum
aiki.
ED shi ne yanayin da
an gane likita da kuma yanayin halayen zamantakewa na zamantakewar al'umma
an yi nazari sosai a cikin binciken daban-daban [7-10, 13, 14, 25]. Overall, an dauki shekarun da ya fi dacewa, tare da karatu da yawa wanda ya nuna yawancin ED tare da shekaru [7, 8, 26];
Alal misali, bayanai daga Massachusetts Male Aging study kammala
wannan lokacin shine mai sauƙin da ya fi dacewa da ED [7]. Bayan shekaru, yawancin yanayin kiwon lafiya sun haɗa da ED [7, 10, 12-14, 26].
A tsawon shekarun tsufa, maza da yawa sukan sha wahala sau ɗaya
ko fiye daga cikin yanayin da aka ambata da aka ambata a baya, ba haka ba
Abin mamaki, su ma sukan yi korafin ED. Saboda wadannan dalilai, yawancin
binciken nazarin annoba da ke kula da lalatawar ED da masu hango ido
Ana gudanar da su a yawancin maza da suka wuce 40 shekaru;
a wasu lokuta, ƙananan bincike ne kawai sun hada da bayanai daga ƙarami
mutane [14-16, 26, 27].
Bugu da ƙari, bayanan daga waɗannan bayanan binciken ya nuna cewa ED ba wani abu ba ne
yanayin har ma tsakanin samari. Mial et al., Alal misali, ya ruwaito
cewa adadin ED shine 29.9% a cikin ƙungiyar 'yan matasan Suratun [15]. Haka kuma, Ponholzer et al. [14] samo irin wannan nau'in ED a cikin jerin jinsin maza da ke cikin shekaru 20-80
shekaru suna shiga cikin aikin kiwon lafiya a yankin Vienna.
Hakazalika, Martins da Abdo [16] An yi amfani da bayanai daga binciken bincike na giciye inda mazaunan 1,947 suke da shekaru 18-40
An tuntube tsofaffi a wurare na 18 manyan biranen Brazil da kuma
an yi hira da shi ta hanyar amfani da tambayoyin da ba a sani ba; gaba ɗaya, 35% daga waɗannan
mutane sun bayar da rahoton wasu nau'o'in matsalolin matsaloli.
A
Babban ƙarfin bincike ɗinmu ya fito ne daga gaskiyar cewa mun kasance daidai
kimantawa da yawan halaye na ED a samari matasa
daga gungun marasa lafiya wadanda suka zo wurinmu
asibiti neman taimakon likita na farko na ED; a cikin wannan mahallin, mun sami cewa
kwata na marasa lafiya da ke fama da ED a yau da kullum
su ne maza a kasa da shekaru 40. Wannan ya tabbatar da baya
bayanan annobar cutar daga nazarin yawan jama'a, ta haka ne ya nuna hakan
ED ba kawai rikitarwa ne na namiji tsufa da aikin aikin ba
rashin ciwo a cikin samari ba kamata su kasance marasa lafiya ba. Mu
Nunawa da tarihin asibitoci na yau da kullum ya sa ya fi dacewa
la'akari da aikin yau da kullum na likitoci da dama basu da
masani da lafiyar namiji; Lalle ne, an ba da low low
rates na ED kima da general likitoci a cikin marasa lafiya mazan
40 shekaru [28], muna jin tsoron cewa ko dai ED ko yin aiki da jima'i ba za a iya yin la'akari da ƙananan yara ba [29].
The
binciken bincikenmu ya nuna cewa kananan marasa lafiya a duniya
mafi koshin lafiya kamar yadda aka kwatanta da mutanen da suka wuce 40 shekaru, suna nuna ƙananan CCI
ƙidaya-tare da ƙananan magunguna, musamman don
CVDs, ƙananan ƙirar BMI, da ƙananan jinin jini.
Hakazalika, kuma ba abin mamaki bane, matasa suna da mahimmanci tT
matakan kamar yadda aka kwatanta da marasa lafiya fiye da shekaru 40, ta haka ne ke haifarwa
yawancin binciken da aka yi na annoba a tsakanin mazaunan Turai [2].
A cikakke, waɗannan bayanan asibiti sun tabbatar da waɗanda aka dawo daga
Binciken Brazil, wanda ya kasa samun babbar ƙungiya tare da
ya tabbatar da kwayoyin cututtuka na ED irin su ciwon sukari da kuma CVDs a cikin maza
shekaru 18-40 shekaru da yawa [16].
Gaba ɗaya, ana saran waɗannan bambance-bambance, ba da gaskiya cewa ED a
samari yawanci suna hade da nauyin tunani da kuma
Abubuwan da suke da alaka da juna wanda yawancin su ke haifarwa
[8, 30, 31]. Bugu da kari, Mialon et al. [15] ya nuna cewa manyan bambance-bambance tsakanin matasa da tsofaffi na ED sun kasance
lafiyar hankali da kuma halin da ake nufi da magunguna. A cikin rukuni na ED
marasa lafiya, mun gano cewa samari sun fi karuwa
taba shan taba da magungunan ƙwayoyi (watau cannabis / marijuana da kuma
cocaine) fiye da marasa lafiya. Bayanan da suka gabata game da amfani da shi na yau da kullum
magunguna-musamman cannabis, opiates, da cocaine - sun nuna babu
hujjoji marasa tabbas na haɗi tare da ED [32-34],
kuma lalle ne yawancin ra'ayoyin da suka nuna suna da tasiri
shan taba cigaba a cigaba da inganta aikin da ba shi da ma'ana
a matasa [7, 34-37].
Saboda yanayin nazarin mu na binciken, ba za mu iya ɗauka ba
idan waɗannan dabi'u na rayuwarsu na iya zama alaƙa da su
farko na ED a cikin samari, amma tabbas yana da ma'ana
cewa su duka suna iya taka rawa tare da wasu dalilai a
inganta aikin rashin aikin aiki. Sabanin haka, wannan na yau da kullum
jaraba ga abubuwan wasanni-wanda zai iya zama yiwuwar
illa ba wai kawai ga lafiyar jima'i-kara kara karfafa damuwa na
tsarin da aka samo daga kallon mu, watau kashi arba'in daga cikin mutanen da suke
zo don neman taimako na farko ga ED yana ƙarƙashin shekaru 40, kuma akai-akai rahotanni
Amfani da abubuwa masu lalacewa, sau da yawa ko da doka ba.
A karshe,
mun ƙwaƙwalga ƙididdigar ƙimar ED a cikin ƙungiyoyi biyu;
an samo kamannin tsararru na ED a tsakanin kungiyoyi. Of
muhimmancin mahimmanci, kusan rabin mutanen da ke ƙasa da shekaru 40
sun sha wahala daga mai tsanani ED kamar Cappelleri et al. [24],
kasancewar wannan daidai ne daidai da abin da aka lura a cikin tsofaffi.
A cikin ra'ayi, wannan binciken zai nuna cewa
Rashin ƙarancin gyaran kafa zai iya zama abin ƙyama a ƙarami
marasa lafiya kamar yadda a cikin tsofaffin maza, don haka suna goyon bayan gaskiyar cewa wannan jima'i
Matsala za ta cancanci dacewa da hankali a kowace aikin likita a yau
duk shekaru daban-daban. Haka kuma, mun kimanta yadda matasa da kuma mazan ED marasa lafiya
ya zana game da yadda ake yin jima'i, kamar yadda aka bayyana ta yin amfani da
daban-daban IIEF domains. Daidai da bayanan da aka gabata sun nuna hakan
canje-canje na tsawon lokaci a cikin ayyuka biyar na jima'i suna waƙa tare
a tsawon lokaci [38],
ba mu lura da kowane muhimmin bambanci a kowane yankin IIEF ba
tsakanin kungiyoyin. A wannan ma'anar, zai yiwu a tantance cewa,
ko da maɗaurori masu mahimmanci ga ED, kayan aikin IIEF ba zai iya zama ba
iya nuna bambanci da ilimin pathophysiology a baya ED. Lalle ne,
kodayake ED, kamar yadda aka fassara shi da aikin IIEF-erectile
yanki, an nuna su zuwa asusu don mafi girma CCI, wanda zai iya zama
a matsayin wani wakilin da ya dace da matsayin lafiyar namiji,
ba tare da la'akari da ilimin ilimin na ED ba [3], Deveci et al. [39] a baya ya kasa nuna cewa IIEF zai iya
nuna bambanci tsakanin kwayoyin halitta da psychogenic ED. Duk da haka, shi ne
hakika gaskiya ne cewa yawan bincike sun nuna cewa ED zai iya zama
bayyanannen ra'ayi na al'amuran CVD [40, 41]. Daga cikin su, Chew et al. [41],
Alal misali, bincika ED a matsayin mai lura da al'amuran CVD a cikin
yawan mazajen da ke tare da ED yana tsakanin 20 da 89 shekarun; wadannan
mawallafa sun sami haɗarin haɗari game da abubuwan CVD a marasa lafiya na ED
ƙarami fiye da shekaru 40. Sabanin haka, ƙimar da aka ƙaddara na ED
domin al'amuran CVD sun kasance a cikin yawan mutanen da suka tsufa [41].
A ƙarshe, waɗannan sakamakon da suka gabata da kuma binciken da muke ciki yanzu na iya bayar da shawarar
cewa samarda ED shine mahimmanci wajen gano matasa da kuma
'yan shekarun da suka kai shekaru masu tsufa wadanda ke da matukar muhimmanci ga ciwon zuciya na zuciya
kima da kuma bayanan likita. Ko da mafi yawan
marasa lafiya a wannan rukuni na zamani zasu sha wahala daga ED,
za a iya kasancewa rabo daga cikinsu na gunaguni na Organic ED na
fannoni daban-daban, tare da ED ne kawai alamaccen sakonni don wani
rikicewar rashin lafiyar jiki (watau atherosclerosis). A cikin wannan
mahallin, Kupelian et al., alal misali, nazarin yawan mutanen 928
ba tare da MeTs ba, ya nuna cewa ED ya kasance tsinkaya ga bunkasa masu tasowa
KASA cikin marasa lafiya tare da BMI na yau da kullum [42],
Ta haka ne karfafa ƙimar ED a matsayin matsala don taimakawa ga matasa
don samun salon rayuwa mai dorewa, wanda zai iya canza yanayin hadarin
cututtuka kamar ciwon sukari da CVD, da sauransu.
Mu
nazarin ba shi da iyakancewa. Na farko, ƙananan ɗan} ungiyarmu
na mutane za su iya rage ma'anar abubuwan da muka gano, yayin da muke shiga
asusun ne kadai marasa lafiya wadanda ake magana da su game da maganin jima'i
Kwafi na asibiti na iya ƙididdige zalunci a cikin sharuddan tsanani
na ED, saboda hakan yana haifar da rasa mutane da yawa tare da tsabta ED kuma
Ƙananan ƙarfafa neman taimakon likita. Duk da haka, muna la'akari da wannan
kuskuren hanya zai kasance daidai a cikin kungiyoyi biyu, saboda haka
ba tare da la'akari da muhimmancin waɗannan binciken ba. Na biyu, ba mu tantance ba
ƙwayar damuwa ko damuwa ta amfani da kayan kirki mai mahimmanci.
A cikin wannan mahallin, dangantakar dangantaka tsakanin ED da ko dai
damuwa ko damuwa, ko duka biyu, tabbas za su iya aiki; hakika, ED
za a iya samu bayan ko dai damuwa ko damuwa wanda, bi da bi, zai iya zama
sakamakon wani jima'i dysfunction. Samun kayan aiki wanda zai iya
nuna bambancin wannan yanayin zai iya zama babban mahimmancin asibiti
musamman ma a cikin matasa. Na uku, bincikenmu bai yi ba
musamman tantance tarihin jima'i na marasa lafiya da kuma jima'i akan su
yaro. Game da wannan, Martins da Abdo [16] ya nuna yadda rashin bayanai game da jima'i a cikin matasan kananan yara
dangantaka da ED saboda yiwuwar tsoro da shakku da tayi ta hanyar taboos
da kuma tsammanin rashin tabbas. Marasa lafiya tare da matsaloli a ko'ina cikin
farawa ta hanyar jima'i ya nuna abin da ya fi girma daga ED, watakila
ƙaddamar da sake zagaye na juyayi da kasawa wanda zai ƙare
halin jima'i na mutum [43].
A ƙarshe, bincikenmu ba la'akari da tattalin arziki ba
al'amurran rayuwa; hakika, yawan kudin da aka samu na gida ya nuna
kasancewa a hade da halayen neman magani, duk da haka
Rashin haɓaka na kudi zai iya wakiltar shamaki [44].
Mun yanke shawarar, duk da haka, kada mu nemi bayanin samun kudin shiga saboda rashin
Sakamakon amsawa zuwa tambayoyin kudin shiga wanda muke samuwa a cikin ainihin rayuwa
Yin aiki na asibiti lokacin ziyara a ofis.
karshe
In
bambanta da abin da aka ruwaito ta hanyar nazarin jama'a game da
yawancin ED a marasa lafiya, bincikenmu ya nuna cewa daya daga cikin
mutane hudu suna neman taimakon likita don ED a cikin aikin likita na yau da kullum
wani asibitin fitar da ƙwaƙwalwa ne wani saurayi a kasa da shekaru 40. Bugu da ƙari,
kusan rabin mutanen samari sun sha wahala daga ED mai tsanani, wannan shine
matsayi daidai da wannan lura a cikin tsofaffi mutane. Motsa zuwa
Ayyukan kula da asibitin yau da kullum, binciken da ake ciki yanzu yana sa mu kara
Ya danganta muhimmancin yin cikakken likita da jima'i
Tarihi da kuma yin jarrabawa ta jiki cikin dukan mutane
ED, ba tare da la'akari da shekarunsu ba. Hakazalika, an bai wa bashi na neman
taimakon likita don cuta game da lafiyar jima'i, waɗannan sakamakon
Bayyana ainihin bukatun da masu samar da kiwon lafiya zasu iya tambayarka
game da matakan jima'i na jima'i, sau ɗaya har ma a cikin samari matasa
40 shekarun. Saboda samfurin samfurin yanzu yana iyakance, muna yiwuwa
ba za a iya samun babban ra'ayi ba; sabili da haka, ƙarin karatu a cikin
Ana buƙatar samfurin samfurori mafi girma don tabbatar da waɗannan sakamakon kuma
don kara fadakar da muhimmancin tasiri na ED kamar yadda harbinger yake
na rashin lafiya a cikin maza a karkashin shekaru 40.
Rikici na sha'awa: Mawallafin ba su da wani rahoto ba.
Bayanin Gudanarwa
category 1
- (A) Zane da ZanePaolo Capogrosso; Andrea Salonia
- (B) Samun BayanaiMichele Colicchia; Eugenio Ventimiglia; Giulia Castagna; Maria Chiara Clementi; Fabio Castiglione
- (C) Tattaunawa da Fassarar BayanaiNazareno Suardi; Andrea Salonia; Francesco Cantiello
category 2
- (A) Rubuta Mataki na ashirin da dayaPaolo Capogrosso; Andrea Salonia
- (B) Binciken shi don Ilimin Masana'antuAndrea Salonia; Alberto Briganti; Rocco Damiano
category 3
- (A) Amincewa na Ƙarshen Mataki na KarsheAndrea Salonia; Francesco Montorsi
References
- 1Gyara abubuwa masu haɗari don hanawa da kuma magance matsalar rashin daidaituwa. J Jima'i Med 2013;10:115-119., , .
- 2Cibiyar Nazarin EMAS. Age-related, , , , , , , , , , , , , , , , , , , ,
canje-canje a cikin lafiyar jama'a da kuma jima'i tsakanin tsofaffi da tsofaffi:
Sakamako daga Nazarin Harkokin Cigaba na Turai (EMAS). J Jima'i Med 2010;7:1362-1380. - 3Is, , , , , , , , , .
Sakamakon sace-tsaren kafa wani tsari mai mahimmanci na matsayin lafiyar namiji?
Shari'ar na Ƙasashen Duniya na Erectile Function-Erectile
Yanayin aikin. J Jima'i Med 2012;9:2708-2715. - 4Erectile, , , , , , , , .
rashin daidaituwa, lokacin farawa da ƙungiyar tare da abubuwan haɗari
in 300 jimla tare da marasa lafiya da ciwo mai tsanani da angiographically
rubuce-rubucen cututtukan cututtukan jini. Eur Urol 2003;44:360-364. - 5Cutar da ke ciki da kuma hadarin ƙwayoyin cututtuka na zuciya: Tsarin maganin bincike na bakwai. J Jima'i Med 2010;7:2805-2816., , , , , , , .
- 6Cutar da ke ciki da kuma cututtukan cututtuka na zuciya: Meta-bincike na binciken jarrabawa. J Am Coll Cardiol 2011;58:1378-1385., , .
- 7Abotance da likita da haɗin gwiwa sun haɗa: Sakamakon Massachusetts Nazarin Yarinyar Matasa. J Urol 1994;151:54-61., , , , .
- 8Harkokin jima'i a Amurka: Yaduwa da jima'i. Jama 1999;281:537-544., , .
- 9Tsarin adadin ƙananan ciwon daji: Tsare-tsaren tsari na nazarin yawan jama'a. Int J Matsarar Res 2002;14:422-432., , , , .
- 10Tsarin jima'i, , , , , , .
da kuma matsalolin haɗari ga dysfunction da dama a cikin maza da ciwon sukari,
hauhawar jini, ko kuma cututtuka biyu: Wani binciken al'umma a tsakanin 1,412 Isra'ila
maza. Clin Cardiol 2003;26:25-30. - 11Halin da ke faruwa a tsakanin mazaunan shekaru 75-95 a cikin jima'i da kuma masu hangen nesa. J Jima'i Med 2012;9:442-453., , , , , , .
- 12M, , , , , , , , , .
bincike game da dangantaka tsakanin zubar da jima'i da ƙananan
urinary fili bayyanar cututtuka saboda mummunan hyperplasia prostatic. Eur Urol 2011;60:809-825. - 13Yanayin lokaci da ƙayyadaddun lalacewar ƙafa a Italiya. Eur Urol 2000;37:43-49., , , , , , , , , , .
- 14Yanayi da yawa da kuma halayen haɗari don cin zarafi a cikin 2869 maza ta amfani da tambayoyin da aka tabbatar. Eur Urol 2005;47:80-85., , , , , .
- 15Rashin jima'i a tsakanin samari: Yanayin jima'i da dalilai masu dangantaka. J Adol Lafiya 2012;51:25-31., , , , .
- 16Abubuwan da ba su da kyau da kuma maganganu masu dangantaka da mutanen Brazil a cikin shekaru 18-40. J Jima'i Med 2010;7:2166-2173., .
- 17Gudun tafiya a cikin yankuna na buƙatun don taimako gabatar ga likitoci likita likitoci: Gabatar da namiji jima'i wahala. J Jima'i Med 2007;4:762-770., , , , .
- 18
- 19Wani sabon hanya na kayyade ƙwararriyar ƙwararru a cikin binciken nazarin lokaci: Ƙaddamar da ingantacciyar. J Chronic Dis 1987;40:373-383., , , .
- 20Cibiyoyin Kula da Lafiya ta Duniya, Zuciya ta Duniya, Lung, da Ciwon Jiki. Ka'idoji na asibiti game da ganewa, kimantawa, da kuma kula da ƙima da kiba a cikin manya - Rahoton Evidence. Ya kasance Res 1998;6(wadata):51-210S.
- 21Ƙungiyar Zuciya ta Amurka; Ƙungiyar Zuciya ta Duniya, Lung, da Ciwon jini. ganewar asali, , , , , , , , , , , ,
da kuma kula da ciwo mai ciwo: Amurkan Amurka
Ƙungiyar / Zuciya ta Zuciya, Lung, da Cibiyar Nazarin Hoto
Sirri. Circulation 2005;112:2735-2752. - 22Ƙungiyar Amirka ta Cibiyar Nazarin Halitta. Bayanin likita don aikin likita don kimantawa da maganin hypogonadism a cikin marasa lafiyar maza-2002. Endocr Yi 2002;8:440-456.
- 23Shafin Farko na Ayyukan Erectile (IIEF): Ƙungiya mai yawa don kima na dysfunction erectile. Urology 1997;49:822-830., , , , , .
- 24Binciken gwaje-gwajen da aka yi amfani da shi na aikin ɗan adam na International Index of Erectile Function. Urology 1999;54:346-351., , , , .
- 25Abinda ya faru, .
na cin hanci da kuma halaye na marasa lafiya kafin da
bayan gabatarwar sildenafil a Ingila: Cross
binciken sashe da kwatanta marasa lafiya. Br Med J 2003;22:424-425. - 26Cutar ilimin cututtuka na lalacewa: Tsarin "Colon Male Survey". Int J Matsarar Res 2000;12:305-311., , , , , .
- 27Tsarin jima'i, , , , , .
da kuma abubuwan haɗari masu zaman kansu don cin zarafi na erectile a Spain: Sakamako
na binciken nazarin Masculina na Epidemiologia de la Disfunction Erectil. J Urol 2001;166:569-574. - 28Kungiyar Nazari ta EDEN. Gudanar da lalacewa ta hanyar yin aiki a cikin al'ada. J Jima'i Med 2009;6:1127-1134., , , , , , ,
- 29“Zan fara duba shi ta yanar gizo”: Katanga da shawo kan shingen don neman lalata tsakanin samari. Swiss Med Wkly 2010;140:348-353., , .
- 30Matsalolin jima'i a cikin lafiya da masu tawayar. Int Clin Psychopharmacol 1998;13(samar da 6):S1-4..
- 31Anatomy, physiology, da kuma pathophysiology na cinikile dysfunction. J Jima'i Med 2010;7:445-475., , , , , , , , , , , .
- 32Hanyar da aka yi a ƙarshen gida a matsayin alama ce ta nakasassu a cikin masu amfani da cannabis. Int J Matsarar Res 2008;20:566-573., , , , , , .
- 33Hanyoyin amfani da cannabis akan lafiyar jima'i. J Jima'i Med 2011;8:971-975., .
- 34Cigarette shan taba: Wani haɗari mai hadarin gaske don rashin ƙarfi? Am J Epidemiol 1994;140:1003-1008., , .
- 35Epidemiology, , , , .
na cin hanci da rashawa a ƙasashe hudu: Nazarin binciken ƙasa na
jimawa da kuma daidaitawa na dysfunction erectile. Urology 2003;61:201-206. - 36Cutar ilimin cututtuka na dasfunni: Rawar da ke tattare da maganin likita da kuma salon rayuwa. Urol Clin North Am 2005;32:403-417., , , .
- 37M, .
sakamako na nicotine a kan ilimin lissafi da kuma batun jima'i cikin
maza masu ba da laushi: Wani baƙin ciki, mai makafi biyu, gwajin gwajin wuribo. J Jima'i Med 2008;5:110-121. - 38Dogon lokaci, , , , , , , .
kimantawa na aikin jima'i a cikin ƙungiyar mata: Ƙasar Olmsted
binciken na urinary symptoms da matsayin kiwon lafiya a tsakanin maza. J Jima'i Med 2009;6:2455-2466. - 39Shin Al'amarin Duniya na Ayyukan Kayan Kama zai iya bambanta tsakanin aikin kwayoyin halitta da psychogenic? BJU Int 2008;102:354-356., , , , , .
- 40Erectile, , , , , , .
dysfunction prospectively dangantaka da cututtukan zuciya na zuciya a cikin
Yaren mutanen Holland: Sakamakon binciken Krimpen. Int J Matsarar Res 2008;20:92-99. - 41Maganin da aka yi amfani da shi na Erectile a matsayin mai hangen nesan ga magungunan ƙwayoyin cuta na atherosclerotic: Abubuwan bincike daga bincike-bincike-bincike. J Jima'i Med 2010;7:192-202., , , , , , , , .
- 42Cutar da ke ciwo kamar yadda aka yi a matsayin mai hangen nesa game da rashin ciwo mai dadi a cikin mutanen tsufa: Sakamakon Massachusetts Nazarin Aiki. J Urol 2006;176:222-226., , , , .
- 43Rubutun daftarin aiki akan dysfunction erectile: Hanyoyi masu mahimmanci a kulawa da mai haƙuri da rashin ciwon kafa. Int J Matsarar Res 2004;16(2 ta samar):S26-39., , , , , .
- 44Shirye-shiryen PDE5i yayi amfani da su tsakanin batutuwan da ke da matsala a cikin lambobi biyu na yawan jama'a. J Jima'i Med 2011;8:3051-3057., , , , , , .